Image

Saudi Arabia, Turkey, and Egypt Immunohematology Market – Industry Trends and Forecast to 2030

Medical Devices

Image

Saudi Arabia, Turkey, and Egypt Immunohematology Market – Industry Trends and Forecast to 2030

  • Medical Devices
  • Published Report
  • Apr 2023
  • Country Level
  • 350 Pages
  • No of Tables: 1
  • No of Figures: 81

Saudi Arabia, Turkey, and Egypt Immunohematology Market, By Product Type (Immunohematology Analyzer and Immunohematology Reagent), Technology (Microplates, Gel Cards, Erythrocyte-Magnetized Technology (EMT), Polymerase Chain Reaction and Others), Application (Antibody Screening and Blood Typing), End User (Blood Banks, Hospitals, Diagnostic and Reference Laboratories, Academic and Research Institutes), Distribution Channel (Direct Sales, Retail Sales and Third Party Distribution) - Industry Trends and Forecast to 2030.

Saudi Arabia, Turkey and Egypt Immunohematology Market Analysis and Insights 

The Saudi Arabia, Turkey, and Egypt immunohematology market is expected to grow in the forecast year due to an increase in the number of product launches with innovation and technological advancement to meet the needs of the market is expected to foster the market's growth. The key market players are increasingly interested in employing new technologies to attract the end-user attention. The usage of blood typing and antibody screening kits or instruments are rapidly growing and offers a tremendous opportunity in this sector. Consequently, the demand for immunohematology products are increasing due to the rising prevalence of trauma incidences and immunohematology disorders worldwide. However, the lack of skilled professionals to carry out hematology testing may hamper the growth of the market.

Saudi Arabia, Turkey and Egypt Immunohematology MarketSaudi Arabia, Turkey and Egypt Immunohematology Market

Saudi Arabia, Turkey and Egypt immunohematology market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 3.8%, 4.2% and 3.0% in the forecast period of 2023 to 2030, respectively for Turkey, Saudi Arabia and Egypt.  

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 – 2020) 

Quantitative Units

Revenue in USD Million

Segments Covered

 Product Type (Immunohematology Analyzer and Immunohematology Reagent), Technology (Microplates, Gel Cards, Erythrocyte-Magnetized Technology (EMT), Polymerase Chain Reaction and Others), Application (Antibody Screening and Blood Typing), End User (Blood Banks, Hospitals, Diagnostic and Reference Laboratories, Academic and Research Institutes), Distribution Channel (Direct Sales, Retail Sales and Third Party Distribution)

Countries Covered

 Saudi Arabia, Turkey and Egypt

Market Players Covered

Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Ortho Clinical Diagnostics (a Subsidiary of QuidelOrtho Corporation) (Egypt), Merck KGaA. (Germany), Beckman Coulter, Inc. (a Subsidiary of Danaher Corporation) (U.S.), Abbott (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and HORIBA (Japan) among others.

 

Market Definition

A subfield of medicine called immunohematology studies how the immune system interacts with blood, specifically identifying blood cell antigens and associated antibodies. It covers the theories and clinical methods involved in contemporary transfusion therapy. Blood transfusion attempts to save human lives have been documented for several centuries.

RBCs contain more than 230 different types of antigens, which can be divided into two main categories based on their chemical makeup: carbohydrates and polypeptides. If the genes are known and found on nearby loci, they are categorized in blood group systems, and if the genes responsible for their formation have not yet been identified, they are categorized in blood group collections. Specific genes that are inherited from parents are responsible for the RBC antigen formation. Because an ABO mismatch can be lethal, the ABO blood group system, which was the first to be identified at the turn of the 20th century, is still regarded as the most significant antigenic system. However, the High cost of hematology instruments, reagents and kits and standards for the approval and commercialization of products is expected to restrain the market growth.

Saudi Arabia, Turkey and Egypt Immunohematology Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

  • Increasing demand for blood and blood products

Most patients who have a major surgical procedure will have a blood transfusion to replace any blood loss during their surgery. Blood transfusions are used for patients who have experienced serious injuries from car crashes or natural disasters. Individuals with an illness that causes anemia, such as leukemia or kidney disease, will often be the recipients of blood transfusions.

Thus, the increasing demand for blood and blood products is expected to accelerate the growth of the immunohematology market significantly in the nearby future.

  • Technological advancements for the development of new products

Since the discovery of the ABO system, numerous important innovations have contributed to a continuous, rapid evolution in the diagnostic methods for in vitro measurements of the antigen-antibody reaction, allowing a significant improvement in the compatibility between blood from donors and recipients.

Apart from the introduction of ABO typing, these methods include the determination of Rh type and phenotype, the direct and indirect antiglobulin tests, cross-matching and consequent identification of antigens and antibodies of clinical relevance, the use of low ionic strength additives and enzyme treatments, the development of monoclonal reagents and solid-phase and microcolumn platforms for performing the pre-transfusion tests.

Thus, technological advancements for the development of new products is expected to drive market growth.

Saudi Arabia, Turkey and Egypt Immunohematology Market

Opportunities

  • Rising awareness about blood donation

Blood donations can yield a variety of blood products, including red cells, platelets and plasma. You may be most familiar with the typical whole blood donation drive seen at workplaces, schools and community events, but there are a few other ways to help give more life through the Red Cross. For cancer patients, blood transfusions can act as a resource to implement platelets back into the body after heavy treatments such as chemo or radiation therapy.

Therefore, a rise in awareness about blood donation is further expected to create a lot of opportunities for the market to grow.

  • Rising cases of blood cancer

Blood cancer is a type of cancer that affects the blood cells. Leukaemia, lymphoma and myeloma are some of the most common types of blood cancer. There are also types called MPNs and MDS. Blood cancer is caused by changes (mutations) in the DNA within blood cells. This causes the blood cells to start behaving abnormally. Thus, rising cases of blood cancer is expected to act as an opportunity for market growth in the coming years.

Restraints/Challenges

  • High Cost of blood testing and transfusion

The transfusion is a burden for both the hospital management systems and the country's economy. To accurately calculate and manage this economic burden is important for sustainable healthcare services. Allogeneic blood transfusion causes variable costs according to different applications in treatment expenditures. It imposes an economic burden to purchase, test and prepare the component suitable for transfusion, deliver blood components to relevant clinics, apply to the recipient, monitor and treat transfusion-induced reactions, dispose of it as medical waste, and file all mandatory information.

Hence, the high cost of blood testing and transfusion, which is further restraining the growth of the market to an extent. 

  • Risk of transfusion- transmitted infections

Transfusion-transmitted infections (TTIs) are infections resulting from the introduction of a pathogen into a person through blood transfusion. A wide variety of organisms, including bacteria, viruses, prions, and parasites, can be transmitted through blood transfusions.

Bacterial contamination of blood products, especially in platelets stored at room temperature, is the most common infectious risk of blood transfusion, occurring in approximately 1 in every 2,000-2,500 platelet transfusions. Transfusion–transmitted sepsis, while less common, can cause severe illness and death. Improved donor screening and improved methods of collection, handling, and storing of blood products have decreased bacterial contamination in recent years.

For instance,

  • In December 2022, according to the information provided by National Center for Biotechnology Information (NCBI), Hepatitis B virus, HCV, and syphilis carry the greatest risk of transfusion-transmittable infection (TTI) in Saudi Arabia. Including HBsAg screening is a necessary precautionary measure to maintain blood safety

Hence the risk of transfusion transmitted infections will act as a challenge to the market.

Recent Development

  • In August 2022, Bio-Rad Laboratories, Inc. announced that the company acquired Scope Fluidics, S.A., a Warsaw, Poland-based developer of cutting-edge technology solutions for the medical diagnostic and healthcare markets, has agreed to sell all of Curiosity Diagnostics, Sp. Z. o. o.'s outstanding shares to Bio-Rad Laboratories, Inc. for a total consideration of up to $170 million, consisting of roughly $100 million in cash and up to $70 million in potential future milestone payments. A sample-to-answer, rapid diagnostics PCR system is being developed by Curiosity Diagnostics, a late-stage, pre-commercial platform firm, for the molecular diagnostics market. This prompted the company to grow its clientele.
  • In July 2022, Beckman Coulter, Inc. announced a partnership with Scopio in order to hasten the deployment of their most recent platforms for peripheral blood smears. In order to completely replace manual microscopy, Scopio's technology uses Full-Field imaging and AI decision support while offering laboratory workers and doctors a genuine workflow boost. The Scopio systems streamline lab operations and enhance workflow in a distributed network with easy-to-use remote viewing. No longer must slides be sent between locations; high quality full-field images may now be transmitted in real time across a secure hospital network. This has aided the corporation in using modern technology to grow its operations.

Saudi Arabia, Turkey, and Egypt Immunohematology Market Scope

Saudi Arabia, Turkey, and Egypt immunohematology market is segmented into five notable segments such as product type, technology, application, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product Type

  • Immunohematology Analyzer
  • Immunohematology Reagent

On the basis of product type, Saudi Arabia, Turkey, and Egypt immunohematology market is segmented into immunohematology analyzer and immunohematology reagent.

Technology

  • Microplates
  • Gel Cards
  • Erythrocyte Magnetized Technology (EMT)
  • Polymerase Chain Reaction
  • Others

On the basis of technology, the Saudi Arabia, Turkey, and Egypt immunohematology market is segmented into microplates, gel cards, erythrocyte magnetized technology (EMT), polymerase chain reaction and others.

Application

  • Antibody Screening
  • Blood Typing

On the basis of application, the Saudi Arabia, Turkey, and Egypt immunohematology market is segmented into antibody screening and blood typing.

End User

  • Blood banks
  • Hospitals
  • Diagnostics and Reference Laboratories
  • Academic and Research Institutes

On the basis of end user, the Saudi Arabia, Turkey, and Egypt immunohematology market is segmented into blood banks, hospitals, diagnostics and reference laboratories, and academic and research institutes.

Distribution Channel

  • Direct Sales
  • Retail Sales
  • Third Party Distribution

On the basis of distribution channel, the Saudi Arabia, Turkey, and Egypt immunohematology market is segmented into direct sales, retail sales and third party distribution.

Saudi Arabia, Turkey and Egypt Immunohematology Market

Saudi Arabia, Turkey and Egypt Immunohematology Market Regional Analysis/Insights      

The immunohematology market is analyzed, and market size insights and trends are provided by country, product type, technology, application, end user and distribution channel.

Competitive Landscape and Saudi Arabia, Turkey and Egypt Immunohematology Market Share Analysis

The immunohematology market competitive landscape provides details of the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the company's focus on the ataxia market.

Some of the key players operating in Saudi Arabia, Turkey, and Egypt immunohematology market are Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Abbott, F. Hoffmann-La Roche Ltd,  Ortho Clinical Diagnostics, Boule, Merck KGaA, Beckman Coulter, Inc., Abbott, Bio-Rad Laboratories, Inc., HORIBA and among others.


SKU-

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Saudi Arabia, Turkey, and Egypt Immunohematology Market is growing with a CAGR of 3.8%, 4.2% and 3.0% in the forecast period by 2030.
The Saudi Arabia, Turkey, and Egypt Immunohematology Market is segmented on the basis of product type, technology, application, end user and distribution channel.
The major players in the Saudi Arabia, Turkey, and Egypt Immunohematology Market are Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Ortho Clinical Diagnostics (a Subsidiary of QuidelOrtho Corporation) (Egypt), Merck KGaA. (Germany), Beckman Coulter, Inc etc.
The countries covered in the Saudi Arabia, Turkey, and Egypt Immunohematology Market are Saudi Arabia, Turkey and Egypt.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials